Vaccines against Enteric Bacterial Pathogens in Poultry
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Veterinary Vaccines".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 650
Special Issue Editors
Interests: vaccine development; avian immunology; antibiotic alternatives; probiotics as feed additives; immunomodulators; poultry health; poultry products safety
Special Issue Information
Dear Colleagues,
As the poultry industry transitions into the "no antibiotic era," it becomes critically imperative to advance the development of vaccines able to target emerging bacterial diseases that pose a significant economic threat to the poultry industry, with necrotic enteritis caused by Clostridium perfringens being a notable example. Additionally, there is a need to control foodborne bacterial pathogens that pose threats to public health, such as Salmonella spp., Campylobacter spp., Escherichia. coli, and Listeria monocytogenes.
This Special Issue is dedicated to showcasing recent scientific and technical advancements in vaccines that are designed to combat enteric bacterial pathogens in poultry. We extend an invitation for contributions in the form of original research or review articles, focusing on innovative vaccination strategies. This includes exploring the use of recombinant technology and nanotechnology in vaccine development and delivery, as well as investigating new immunomodulators and adjuvants like Toll-like receptor ligands, cytokines, nanoparticles, probiotics, and other novel agents to enhance vaccine immunogenicity and protective efficacy against the aforementioned bacterial pathogens.
Dr. Khaled Abdelaziz
Dr. Ahmed Ali
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccine
- immunomodulators
- adjuvants
- chicken
- poultry
- bacteria
- necrotic enteritis
- Clostridium perfringens
- Salmonella
- Campylobacter
- E. coli
- Listeria
